SCHEMBL4660016

SCHEMBL4660016

COCC(C#N)(C(=O)O)C(c1ccccc1OC)c1ccnc2ccccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.38
MAPK1 P28482 2/20 0.38
RAB9A P51151 2/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
POLB P06746 3/20 0.36
HTT P42858 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
HIF1A Q16665 1/20 0.36
P2RX7 Q99572 3/20 0.36
FABP5 Q01469 1/20 0.36
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
ACHE P22303 1/20 0.35
HTR2C P28335 1/20 0.34
HTR2B P41595 1/20 0.34
TDP1 Q9NUW8 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4659913 0.85 ESR1 (0.42) KDM4EMAPK1RAB9AGAAMAPT
SCHEMBL4661570 0.84 MAPT (0.40) KDM4EMAPK1GAAMAPTPOLB
SCHEMBL6433797 0.84 ESR1 (0.45) KDM4EGAAPOLBHTTL3MBTL1
SCHEMBL4659952 0.84 ESR1 (0.45) KDM4EGAAPOLBHTTL3MBTL1
SCHEMBL4659954 0.84 ESR1 (0.45) KDM4EGAAPOLBHTTL3MBTL1
SCHEMBL4662613 0.84 ESR1 (0.45) KDM4EGAAPOLBHTTL3MBTL1
SCHEMBL4661464 0.80 ESR1 (0.42) KDM4EMAPK1RAB9AGAAMAPT
SCHEMBL4662623 0.79 ESR1 (0.41) KDM4EMAPK1RAB9AGAAMAPT
SCHEMBL4662626 0.78 ESR1 (0.41) KDM4EMAPK1RAB9AGAAMAPT
SCHEMBL4660062 0.78 PDE4D (0.43) KDM4ERAB9AGAAMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070299105-A1 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use WYETH (US) 2007-12-27 US claimed
EP-1620102-B1 3-(1-NAPHTHYL)-2-CYANOPROPANOIC ACID DERIVATIVES AS ESTROGEN RECEPTOR LIGANDS WYETH CORP (US) 2008-12-24 EP disclosed
US-20070299105-A1 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use WYETH (US) 2007-12-27 US disclosed
EP-1620102-A2 3-(1-NAPHTHYL)-2-CYANOPROPANOIC ACID DERIVATIVES AS ESTROGEN RECEPTOR LIGANDS Wyeth (US) 2006-02-01 EP disclosed
US-20050256132-A1 Use of ER selective NF-kB inhibitors for the treatment of sepsis WYETH (US) 2005-11-17 US disclosed
US-20050004164-A1 2-Cyanopropanoic acid amide and ester derivatives and methods of their use WYETH 2005-01-06 US disclosed
WO-2004099150-A2 3-(1-NAPHTHYL)-2-CYANOPROPANOIC ACID DERIVATIVES AS ESTROGEN RECEPTOR LIGANDS WYETH (US) 2004-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256132-A1 Use of ER selective NF-kB inhibitors for the treatment of sepsis NFKBIA, IKBKB, NFKB2 KDM4E 1711/4885MAPK1 445/4885RAB9A 3998/4885
US-20070299105-A1 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use HCAR2, PCCA, MCCC2 KDM4E 2551/4885MAPK1 1030/4885RAB9A 3505/4885
US-20050004164-A1 2-Cyanopropanoic acid amide and ester derivatives and methods of their use HCAR2, PCCA, MCCC2 KDM4E 2836/4885MAPK1 1112/4885RAB9A 3732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.